ImportRefusal LogoImportRefusal

B. Braun US Pharmaceutical Manufacturing, LLC

⚠️ High Risk

FEI: 2021236 • Irvine, CA • UNITED STATES

FEI

FEI Number

2021236

📍

Location

Irvine, CA

🇺🇸
🏢

Address

2525 Mcgaw Ave, , Irvine, CA, United States

High Risk

FDA Import Risk Assessment

56.1
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

18
Total Refusals
4
Unique Violations
11/19/2024
Latest Refusal
11/27/2006
Earliest Refusal

Score Breakdown

Violation Severity
63.7×40%
Refusal Volume
47.4×30%
Recency
77.1×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

17914×

AGR RX

The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

Refusal History

DateProductViolationsDivision
11/19/2024
55RP74DEXTROSE (PHARMACEUTIC NECESSITY)
179AGR RX
Division of Northern Border Imports (DNBI)
11/19/2024
65RDK19SODIUM CHLORIDE (REPLENISHER)
179AGR RX
Division of Northern Border Imports (DNBI)
11/19/2024
65RDK19SODIUM CHLORIDE (REPLENISHER)
179AGR RX
Division of Northern Border Imports (DNBI)
11/15/2024
64ZDK01CALCIUM CHLORIDE, DEXTROSE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, SODIUM LACTATE, PERITONEAL DIALYSIS
179AGR RX
Division of Northern Border Imports (DNBI)
11/15/2024
65RDK19SODIUM CHLORIDE (REPLENISHER)
179AGR RX
Division of Northern Border Imports (DNBI)
11/15/2024
65RDK19SODIUM CHLORIDE (REPLENISHER)
179AGR RX
Division of Northern Border Imports (DNBI)
11/15/2024
65RDK19SODIUM CHLORIDE (REPLENISHER)
179AGR RX
Division of Northern Border Imports (DNBI)
11/12/2024
65RCN99REPLENISHER N.E.C.
179AGR RX
Division of Southeast Imports (DSEI)
11/12/2024
65RCN99REPLENISHER N.E.C.
179AGR RX
Division of Southeast Imports (DSEI)
11/12/2024
65RCN99REPLENISHER N.E.C.
179AGR RX
Division of Southeast Imports (DSEI)
11/12/2024
65RCN99REPLENISHER N.E.C.
179AGR RX
Division of Southeast Imports (DSEI)
11/12/2024
65RCN99REPLENISHER N.E.C.
179AGR RX
Division of Southeast Imports (DSEI)
8/18/2023
65RDN14POTASSIUM CHLORIDE (REPLENISHER)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/29/2022
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
3280FRNMFGREG
Division of Southeast Imports (DSEI)
1/9/2020
65FAK02WATER, PURIFIED, U.S.P. (PHARMACEUTIC AID)
179AGR RX
Division of Northern Border Imports (DNBI)
1/16/2015
65RCY12POTASSIC SALINE (INJECTION) (REPLENISHER)
179AGR RX
New Orleans District Office (NOL-DO)
5/27/2008
65FCN04WATER (PHARM AID) FOR INJ, STERILE, U.S.P.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
11/27/2006
65HDN04HETASTARCH (PLASMA VOLUME EXTENDER)
75UNAPPROVED
Florida District Office (FLA-DO)

Frequently Asked Questions

What is B. Braun US Pharmaceutical Manufacturing, LLC's FDA import refusal history?

B. Braun US Pharmaceutical Manufacturing, LLC (FEI: 2021236) has 18 FDA import refusal record(s) in our database, spanning from 11/27/2006 to 11/19/2024.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. B. Braun US Pharmaceutical Manufacturing, LLC's FEI number is 2021236.

What types of violations has B. Braun US Pharmaceutical Manufacturing, LLC received?

B. Braun US Pharmaceutical Manufacturing, LLC has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about B. Braun US Pharmaceutical Manufacturing, LLC come from?

All FDA import refusal data for B. Braun US Pharmaceutical Manufacturing, LLC is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.